Short paper
Comparison of nose and face mask CPAP therapy for sleep apnoea
Respiratory Medicine Unit, Department of Medicine,
University of Edinburgh, Royal Infirmary, Edinburgh EH3 9YW, UK
Correspondence to: Dr I L Mortimore, Scottish National Sleep Laboratory, Royal Infirmary, Edinburgh EH3 9YW, UK.
Received 18 April 1997; Returned to authors 30 June 1997; Revised version received 10 December 1997; Accepted for publication 12 December 1997
BACKGROUND
Many patients with sleep
apnoea/hypopnoea syndrome (SAHS) find nasal continuous positive airway
pressure (CPAP) treatment unsatisfactory due to side effects related to
mouth air leakage. A study was performed to compare side effects with
face mask and nose mask CPAP therapy in patients with SAHS, with and
without uvulopalatopharyngoplasty (U3P).
METHODS
Twenty newly diagnosed patients with SAHS
took part in a randomised double limb trial of face or nose mask CPAP
therapy (four weeks per limb) in which CPAP compliance in terms of
machine run time was measured and patients answered a symptom
questionnaire on side effects resulting from the mask. Ten patients
with SAHS with U3P (SAHS/U3P) who were already regular users of nasal
CPAP were also given a four week trial of face mask CPAP to compare compliance and symptoms. Ten patients with SAHS were matched with the
10 SAHS/U3P patients for body mass index, age, apnoea/hypopnoea index,
and CPAP pressure. Long term compliance was estimated one year after
the mask comparison studies.
RESULTS
For patients with SAHS nightly compliance
was higher with a nose mask (mean (SE) 5.3 (0.4) hours/night CPAP) than
with a face mask (4.3 (0.5) hours/night CPAP), p = 0.01 (mean
difference 1.0 hour/night, 95% CI 1.8 to 0.3). Nose masks were rated
more comfortable by 19 of 20 patients (p<0.001) despite more mouth
leak related symptoms. For SAHS/U3P patients compliance was marginally
higher with nose masks (5.1 (0.7) hours/night CPAP) than with face
masks (4.0 (0.8) hours/night CPAP), p = 0.07 (mean difference 1.1 hour/night, 95% CI 2.1 to 0.1). Nose masks were rated more comfortable
by seven of 10 patients. There were no significant differences in side
effect scores with face and nose masks. At one year nine of 10 SAHS
patients and nine of 10 SAHS/U3P patients were still using CPAP.
Compliance was 5.4 (0.6) hours/night for the SAHS patients and 3.5 (0.4) hours/night for the SAHS/U3P patients, p = 0.02 (mean difference
1.9 hour/night, 95% CI 3.6 to 0.3).
CONCLUSIONS
Compliance is greater with nose mask
CPAP than with face mask CPAP because the overall comfort is better and
compensates for increased symptoms associated with mouth leakage.
Improved face mask design is needed.
© 1998 by Thorax
This article has been cited by other articles:
-
Aloia, M. S., Stanchina, M., Arnedt, J. T., Malhotra, A., Millman, R. P.
(2005). Treatment Adherence and Outcomes in Flexible vs Standard Continuous Positive Airway Pressure Therapy. Chest
127: 2085-2093
[Abstract] [Full Text] -
Gordon, P, Sanders, M H
(2005). Sleep {middle dot} 7: Positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome. Thorax
60: 68-75
[Abstract] [Full Text] -
Willson, G.N., Piper, A.J., Norman, M., Chaseling, W.G., Milross, M.A., Collins, E.R., Grunstein, R.R.
(2004). Nasal versus full face mask for noninvasive ventilation in chronic respiratory failure. Eur Respir J
23: 605-609
[Abstract] [Full Text] -
Beecroft, J., Zanon, S., Lukic, D., Hanly, P.
(2003). Oral Continuous Positive Airway Pressure for Sleep Apnea: Effectiveness, Patient Preference, and Adherence. Chest
124: 2200-2208
[Abstract] [Full Text] -
Neill, A.M., Wai, H.S., Bannan, S.P.T., Beasley, C.R., Weatherall, M., Campbell, A.J.
(2003). Humidified nasal continuous positive airway pressure in obstructive sleep apnoea. Eur Respir J
22: 258-262
[Abstract] [Full Text] -
Massie, C. A., Hart, R. W.
(2003). Clinical Outcomes Related to Interface Type in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome Who Are Using Continuous Positive Airway Pressure. Chest
123: 1112-1118
[Abstract] [Full Text] -
Littner, M. R.
(2003). Continuous Positive Airway Pressure: By Nose or Mouth?. Chest
123: 662-664
[Full Text] -
Rakotonanahary, D., Pelletier-Fleury, N., Gagnadoux, F., Fleury, B.
(2001). Predictive Factors for the Need for Additional Humidification During Nasal Continuous Positive Airway Pressure Therapy. Chest
119: 460-465
[Abstract] [Full Text] -
Brown, L. K.
(2000). Back to Basics: If It’s Dry, Wet It : The Case for Humidification of Nasal Continuous Positive Airway Pressure Air. Chest
117: 617-619
[Full Text] -
Martins de Araujo, M. T., Vieira, S. B., Vasquez, E. C., Fleury, B.
(2000). Heated Humidification or Face Mask To Prevent Upper Airway Dryness During Continuous Positive Airway Pressure Therapy*. Chest
117: 142-147
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
